The effect of lifestyle modification on bone density in middle-aged women with osteopenia

Investigation of the effect of lifestyle modification based on Health Belief Training Model on bone density in middle-aged women with osteopenia

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20171030037093N39

Enrollment

Registered

2020-06-05

Start date

2020-04-08

Completion date

Unknown

Last updated

2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis. Osteoporosis without current pathological fracture

Interventions

Intervention 1: Intervention group: four 40-60 minute training sessions for consecutive weeks, aimed at modifying lifestyle based on health belief model on bone density in middle-aged women with osteo

Eligibility

Sex/Gender

Female

Age

40 Years to 55 Years

Inclusion criteria

Inclusion criteria: Middle-aged women (40-55 years) According to the Bone Mineral Density (BMD) in the case file, they have osteopenia. Not postmenopausal. Do not use corticosteroids or chemotherapy drugs for up to a year before taking the study. Do not use anti-osteoporotic drugs. Do not suffer from any rheumatic diseases, types of cancer and bone metastasis, thyroid and parathyroid problems, and bone fractures, which will be done by referring to patients' electronic records. Tend to be involved in research.

Exclusion criteria

Exclusion criteria: Not to be a client of Isfahan Oil Company clinic. Do not reside in Isfahan.

Design outcomes

Primary

Measure	Time frame
Knowledge. Timepoint: Before and after the study. Method of measurement: Questionnaire.;Attitude. Timepoint: Before and after the study. Method of measurement: Questionnaire.;Perceived sensitivity. Timepoint: Before and after the study. Method of measurement: Questionnaire.;Perceived severity. Timepoint: Before and after the study. Method of measurement: Questionnaire.;Perceived benefits. Timepoint: Before and after the study. Method of measurement: Questionnaire.;Perceived barriers. Timepoint: Before and after the study. Method of measurement: Questionnaire.;Guidelines for action. Timepoint: Before and after the study. Method of measurement: Questionnaire.;Urinary telopeptide. Timepoint: Before and after the study. Method of measurement: Questionnaire.;Physical activity. Timepoint: Before and after the study. Method of measurement: Questionnaire.;Calcium intake. Timepoint: Before and after the study. Method of measurement: Questionnaire.;Vitamin D intake. Timepoint: Before and after the study. Method of measurement: Questionnaire.	—

Measure

Time frame

Knowledge. Timepoint: Before and after the study. Method of measurement: Questionnaire.;Attitude. Timepoint: Before and after the study. Method of measurement: Questionnaire.;Perceived sensitivity. Timepoint: Before and after the study. Method of measurement: Questionnaire.;Perceived severity. Timepoint: Before and after the study. Method of measurement: Questionnaire.;Perceived benefits. Timepoint: Before and after the study. Method of measurement: Questionnaire.;Perceived barriers. Timepoint: Before and after the study. Method of measurement: Questionnaire.;Guidelines for action. Timepoint: Before and after the study. Method of measurement: Questionnaire.;Urinary telopeptide. Timepoint: Before and after the study. Method of measurement: Questionnaire.;Physical activity. Timepoint: Before and after the study. Method of measurement: Questionnaire.;Calcium intake. Timepoint: Before and after the study. Method of measurement: Questionnaire.;Vitamin D intake. Timepoint: Before and after the study. Method of measurement: Questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZiba Farajzadegan

Esfahan University of Medical Sciences

farajzadegan@med.mui.ac.ir+98 31 3668 0048

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026